A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.
Clinical trial NCT01924858 · TERMINATED
Trial details
- NCT number
- NCT01924858
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-19
- Primary completion
- 2014-03-03
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.